LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $102,000 | +15.9% | 3,600 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $88,000 | -59.8% | 3,600 | -45.5% | 0.01% | -57.1% |
| Q4 2019 | $219,000 | +128.1% | 6,600 | +32.0% | 0.01% | +55.6% |
| Q3 2019 | $96,000 | +4700.0% | 5,000 | +614.3% | 0.01% | – |
| Q1 2019 | $2,000 | -89.5% | 700 | +386.1% | 0.00% | -100.0% |
| Q4 2017 | $19,000 | 0.0% | 144 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $19,000 | -29.6% | 144 | -98.1% | 0.00% | 0.0% |
| Q2 2017 | $27,000 | -94.9% | 7,500 | -57.0% | 0.00% | -95.5% |
| Q1 2017 | $530,000 | -73.0% | 17,424 | -86.8% | 0.02% | -68.6% |
| Q4 2016 | $1,965,000 | +281.6% | 131,695 | +654.4% | 0.07% | +204.3% |
| Q3 2016 | $515,000 | +560.3% | 17,457 | +29.0% | 0.02% | +475.0% |
| Q2 2016 | $78,000 | -73.5% | 13,537 | -73.4% | 0.00% | -78.9% |
| Q1 2016 | $294,000 | +281.8% | 50,931 | +832.3% | 0.02% | +375.0% |
| Q4 2015 | $77,000 | – | 5,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |